TrialDiabetes, metabolic syndrome and obesity : targets and therapy2023

Teneligliptin, a DPP-4 Inhibitor, Improves Vascular Endothelial Function via Divergent Actions Including Changes in Circulating Endothelial Progenitor Cells.

Naoyuki Akashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.